These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26740985)

  • 1. Novel combined candidate--new hopes for COPD maintenance therapy!?
    Mihălţan F; Ulmeanu R
    Pneumologia; 2015; 64(3):9-11. PubMed ID: 26740985
    [No Abstract]   [Full Text] [Related]  

  • 2. Emerging trends in the therapy of COPD: bronchodilators as mono- and combination therapies.
    Fitzgerald MF; Fox JC
    Drug Discov Today; 2007 Jun; 12(11-12):472-8. PubMed ID: 17532532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
    Cazzola M; Molimard M
    Pulm Pharmacol Ther; 2010 Aug; 23(4):257-67. PubMed ID: 20381630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel bronchodilators for the treatment of chronic obstructive pulmonary disease.
    Matera MG; Page CP; Cazzola M
    Trends Pharmacol Sci; 2011 Aug; 32(8):495-506. PubMed ID: 21683458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.
    Alcázar Navarrete B; Casanova C; Miravitlles M; de Lucas P; Riesco JA; Rodríguez González-Moro JM;
    Arch Bronconeumol; 2015 Apr; 51(4):193-8. PubMed ID: 25540900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drugs for chronic obstructive pulmonary disorder].
    Bakke PS; Høines KJ
    Tidsskr Nor Laegeforen; 2019 Oct; 139(14):. PubMed ID: 31592602
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease.
    Hughes AD; Jones LH
    Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
    López-Campos JL
    Arch Bronconeumol; 2013 Jul; 49(7):279-81. PubMed ID: 23122560
    [No Abstract]   [Full Text] [Related]  

  • 10. Bronchodilators: current and future.
    Cazzola M; Matera MG
    Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.
    Cazzola M; Beeh KM; Price D; Roche N
    Pulm Pharmacol Ther; 2015 Apr; 31():68-78. PubMed ID: 25727846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging therapeutic strategies in COPD.
    Babu KS; Morjaria JB
    Drug Discov Today; 2015 Mar; 20(3):371-9. PubMed ID: 25462534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Options for Stable Chronic Obstructive Pulmonary Disease: Current Recommendations and Unmet Needs.
    Yawn BP; Kim V
    Cleve Clin J Med; 2018 Feb; 85(2 Suppl 1):S28-S37. PubMed ID: 29494330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical profile of roflumilast].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():25-32. PubMed ID: 21316553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
    Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
    Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large trials, new knowledge: the changing face of COPD management.
    De Soyza A; Calverley PM
    Eur Respir J; 2015 Jun; 45(6):1692-703. PubMed ID: 25792640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
    Ray NC; Alcaraz L
    Expert Opin Ther Pat; 2009 Jan; 19(1):1-12. PubMed ID: 19441894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ▾Glycopyrronium for COPD.
    Drug Ther Bull; 2013 Jun; 51(6):66-8. PubMed ID: 23744364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new algorithm for the management of COPD.
    Cooper CB; Barjaktarevic I
    Lancet Respir Med; 2015 Apr; 3(4):266-8. PubMed ID: 25890644
    [No Abstract]   [Full Text] [Related]  

  • 20. COPD: should we go for GOLD?
    Scullion JE
    Br J Nurs; 2015 Nov 12-25; 24(20):1024-5. PubMed ID: 26559107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.